Evaluation of the child with suspected mitochondrial liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 3, 2013, Pages 269-276

  Molleston, Jean P ^a   Sokol, Ronald J ^b   Karnsakul, Wikrom ^c   Miethke, Alexander ^d   Horslen, Simon ^e   Magee, John C ^f   Romero, René ^g   Squires, Robert H ^h   Van Hove, Johan L K ⁱ  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e SEATTLE CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHLORAMPHENICOL; LACTIC ACID; MACROLIDE; MITOCHONDRIAL DNA; PROPOFOL; QUINOLONE DERIVATIVE; RINGER LACTATE SOLUTION; TETRACYCLINE; VALPROIC ACID;

BIOSYNTHESIS; CARBOHYDRATE INTAKE; CHOLESTASIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAT INTAKE; GENE MUTATION; HUMAN; LACTIC ACIDOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MEDLINE; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL LIVER DISEASE; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; CHILD; LIVER; LIVER DISEASES; MITOCHONDRIAL DISEASES; MITOCHONDRION; PRACTICE GUIDELINE;

CHILD; HUMANS; LIVER; LIVER DISEASES; MITOCHONDRIA; MITOCHONDRIAL DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84883744294     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31829ef67a     Document Type: Review

References (50)

1. DiMauro S, Schon EA Mitochondrial respiratory-chain diseases. N Engl J Med 2003; 348: 2656-68. (Pubitemid 36741594)
2. Garcia-Cazorla A., De Lonlay P, Rustin P, et al. Mitochondrial respiratory chain deficiencies expressing the enzymatic deficiency in the hepatic tissue: a study of 31 patients. J Pediatr 2006; 149: 401e3-5e3.
3. Haas RH, Parikh S, Falk M.J., et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008; 94: 16-37.
4. Koopman WJH, Willems PHGM, Smeitink JAM. Monogenic mitochondrial disorders. N Engl J Med 2012; 366: 1132-41.
5. Spinazzola A, Invernizzi F, Carrara F., et al. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 2009; 32: 143-58.
6. Wong L-JC. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010; 16: 154-62.
7. Kemp JP, Smith PM, Pyle A, et al Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain 2011; 134: 183-95.
8. Lee WS, Sokol RJ Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 2007; 45: 1555-65. (Pubitemid 46918340)
9. Bennett MJ. Pathophysiology of fatty acid oxidation disorders. J Inherit Metab Dis 2010; 33: 533-7.
10. Bonnefont JP, Specola NB, Vassault A, et al The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 1990; 150: 80-5.
11. Wortmann SB, Rodenburg RJT, Jonckheere A, et al. Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain 2009; 132: 136-46.
12. Saneto RP, Naviaux RK Polymerase gamma disease through the ages. Dev Disabil Res Rev 2010; 16: 163-74.
13. Tang S, Wang J, Lee N-C, et al. Mitochondrial DNA polymerase g mutations: an ever expanding molecular and clinical spectrum. J Med Genet 2011; 48: 669-81.
14. Dimmock DP, Zhang Q, Dionisi-Vici C, et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 2008; 29: 330-1.
15. Labarthe F, Dobbelaere D, Devisme L., et al. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J Hepatol 2005; 43: 333-41. (Pubitemid 40956888)
16. Pronicka E, Weglewska-Jurkiewicz A, Taybert J., et al. Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet 2011; 52: 61-6.
17. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006; 38: 570-5.
18. Wong LJ, Brunetti-Pierri N, Zhang Q., et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 2007; 46: 1218-27. (Pubitemid 350144786)
19. Van Hove J.L., Saenz MS, Thomas J.A., et al. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr Res 2010; 68: 159-64.
20. Hakonen AH, Isohanni P, Paetau A., et al. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007; 130: 3032-40. (Pubitemid 350033977)
21. Rötig A., Cormier V, Blanche S., et al. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990; 86: 1601-8. (Pubitemid 20372610)
22. den Boer MEJ, Wanders RJA, Morris AAM, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 2002; 109: 99-104. (Pubitemid 34049432)
23. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006; 142C: 77-85.
24. Olpin SE, Afifi A, Clark S., et al. Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency. J Inherit Metab Dis 2003; 26: 543-57. (Pubitemid 37321533)
25. Schiff M, Froissart R, Olsen RKJ, et al. Electron transfer flavoprotein deficiency: functional and molecular aspects. Mol Genet Metab 2006; 88: 153-8.
26. Lopriore E, Reinoud JBJG, Verhoeven NM, et al. Carnitine-acylcarnitine translocase deficiency: phenotype, residual enzyme activity and outcome. Eur J Pediatr 2001; 160: 101-4. (Pubitemid 32204535)
27. He M, Rutledge SL, Kelly D.R., et al. A new genetic disorder in mitochondrial fatty acid (-oxidation: ACAD9 deficiency. Am J Hum Genet 2007; 81: 87-103. (Pubitemid 47001159)
28. Schara U, von Kleist-Retzow JC, Lainka E, et al. Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J Inherit Metab Dis 2011; 34: 197-201.
29. Zeharia A, Shaag A, Pappo O., et al. Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 2009; 85: 401-7.
30. Van Coster R., Smet J, George E., et al. Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 2001; 50: 658-65. (Pubitemid 33009992)
31. Ye F, Hoppel CL Measuring oxidative phosphorylation in human skin fibroblasts. Anal Biochem 2013; 437: 52-8.
32. Kotarsky H, Karikoski R, Morgelin M., et al. Characterization of complex III deficiency and liver dysfuntion in GRACILE syndryome caused by a BCS1L mutation. Mitochondrion 2010; 10: 497-509.
33. Valnot I, Osmond S, Gigarel N., et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 2000; 67: 1104-9.
34. Vedrenne V, Galmiche L, Chretien D., et al. Mutation in the mitochondrial translation elongation factor EFTs results in severe infantile liver failure. J Hepatol 2012; 56: 294-7.
35. Lee NC, Dimmock D, Hwu W.L., et al. Simultaneous detection of mitochondrial DNA depletion and single-exon deletion in the deoxyguanosine gene using array-based comparative genomic hybridisation. Arch Dis Child 2009; 94: 55-8.
36. Smet J, Seneca S, De Paepe B, et al. Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA. Electrophoresis 2009; 30: 3565-72.
37. Teitelbaum JE, Berde CB, Nurko S, et al Diagnosis and Management of MNGIE Syndrome in Children: case report and review of the literature. J Pediatr Gastroenterol Nutr 2002; 35: 377-83.
38. Elo JM, Yadavalli SS, Euro L, et al Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet 2012; 21: 4521-9.
39. Hirano M, Garone C, Quinzii CM CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta 2012; 1820: 625-31.
40. Cormier-Daire V., Bonnefont J-P, Rustin P, et al. Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 1994; 124: 63-70. (Pubitemid 24027288)
41. Fearing MK, Israel EJ, Sahai I, et al Case records of the Massachusetts General Hospital. Case 12-2011. A 9-month-old boy with acute liver failure. N Engl J Med 2011; 364: 1545-56.
42. Calvo SE, Compton AG, Hershman S.G., et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 2012; 4: 118ra10.
43. Lieber DS, Calvo SE, Shanahan K, et al Targeted exome sequencing of suspected mitochondrial disorders. Neurology 2013; 80: 1762-70.
44. Dimmock DP, Dunn JK, Feigenbaum A, et al Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl 2008; 14: 1480-5.
45. Thomson M, McKiernan P, Buckels J., et al. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 1998; 26: 478-81. (Pubitemid 28160703)
46. Dubern B, Broue P, Dubuisson C., et al. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation 2001; 71: 633-7. (Pubitemid 32268064)
47. Sokal EM, Sokol R, Cormier V., et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999; 158:S81-4.
48. Cohen BH. Pharmacologic effects on mitochondrial function. Dev Disabil Res Rev 2010; 16: 189-99.
49. Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia 2007; 62: 690-701. (Pubitemid 46929963)
50. Parikh S, Saneto R, Falk M.J., et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009; 11: 414-30.